The treatment medication may help treat acrophobic sufferers.
The U.S. Food and Drug Administration has approved the drug as a first-line treatment for patients with mild to moderate symptoms.
It’s the first time a drug has been approved for treating people with severe symptoms of anxiety and fear.
In a study published online in the American Journal of Psychiatry, researchers looked at the effect of the drug on patients with chronic anxiety disorder who had had no treatment for anxiety for at least three months.
They found that the drug reduced symptoms of panic attacks, anxiety and depression by 60 percent, compared to a placebo.
The drug’s effects were strongest in patients with severe or comorbid anxiety disorders, such as anxiety and panic disorder, and were not observed in healthy patients.
In the next phase of clinical trials, researchers plan to see whether the drug can help reduce symptoms of severe anxiety in patients who are not using the drug to treat anxiety.
The FDA approved the medication last month.
It is currently available as a generic from generic drugstores and will be distributed through a pharmacy.